Dutch Cancer Foundation (KWF) grant for Dömling
Prof. Alex Dömling, Drug Design group of GRIP, together with co-workers of the UMCG (Profs. H. Nijmans and P. Elsinga) recently was awarded a grant of approx. €840.000 by the Dutch Cancer Foundation (KWF) research and implementation programme. The project is titled: Non-invasive whole-body imaging of immune checkpoints using radiolabeled small molecules as predictive biomarker for response to therapy.
In the project, small molecules will be developed for use as PET tracers and provide proof-of-concept for their use as a predictive biomarker. The multidisciplinary team of clinicians, chemists, nuclear medicine specialists and preclinical research staff involved in this project makes us uniquely suited to develop an imaging product with near-future clinical applications.
| Last modified: | 08 June 2017 1.25 p.m. |
More news
-
29 April 2025
Impact | Rubber recycling
In the coming weeks the nominees for the Ben Feringa Impact Award 2025 will introduce themselves and their impactful research or project. This week: Francesco Picchioni on his innovative way to recycle rubber.
-
29 April 2025
Impact | Improving Human-AI Decision-Making in healthcare
In the coming weeks the nominees for the Ben Feringa Impact Award 2025 will introduce themselves and their impactful research or project. This week: Andra Cristiana Minculescu on her research project on Human-AI Decision-Making in healthcare.
-
28 April 2025
Engineering Smart Decisions for a Dynamic World
Dynamical systems, i.e. mathematical models that describe how things evolve over time, are at the heart of much of the modern world. The real challenge, however, lies in shaping the systems’ behaviour to achieve a specific goal.